![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/10 | |
A61K 47/10 | |||
A61K 31/5513 | |||
A61P 25/18 | |||
A61K 47/02 |
(11) | Number of the document | 1646393 |
(13) | Kind of document | T |
(96) | European patent application number | 04748853.1 |
Date of filing the European patent application | 2004-07-22 | |
(97) | Date of publication of the European application | 2006-04-19 |
(45) | Date of publication and mention of the grant of the patent | 2013-09-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/NZ2004/000158 |
Date | 2004-07-22 |
(87) | Number | WO 2005/007168 |
Date | 2005-01-27 |
(30) | Number | Date | Country code |
52714203 | 2003-07-23 | NZ |
(72) |
SURMAN, Peter William, NZ
HOULDER-LEVELL, Sharon, NZ
MAK, Wai Bik, NZ
MCLEOD, Andrew Douglas, NZ
|
(73) |
Douglas Pharmaceuticals Limited,
Central Park Drive, Lincoln, Auckland,
NZ
|
(54) | A STABLE CLOZAPINE SUSPENSION FORMULATION |
A STABLE CLOZAPINE SUSPENSION FORMULATION |